American HealthCare Capital is pleased to introduce a CLIA certified Pathology and Molecular Reference Lab for sale based in Florida. The lab specializes in Anatomic Pathology Testing and Molecular Testing, and they have recently started providing COVID-19 Testing. Although the company has largely been focused on Florida business to date, they are actively pursuing out of state referral sources and already have a small footprint in multiple states such as Georgia, Illinois, Michigan, and North Carolina. The company’s payer mix is 50% Medicare and 50% private insurance. Gross revenues have grown exponentially since the company’s inception, reaching almost $1.5 million in 2019 with an adjusted EBITDA margin near 30%. In 2020, they are currently on pace to gross over $4 million with a similar EBITDA margin, and they are expected to be in the $6 – $7 million range in 2021. This business opportunity includes the lab’s certifications, equipment, staff, and book of business. All serious offers will be considered.